Anne-Marie Koop

122 Author Year Title PMID Embase Accession ID Khan, et al. 84 2015 Effects of ranolazine on exercise capacity, 26401256 right ventricular indices, and hemodynamic characteristics in pulmonary arterial hypertension: a pilot study. Sakao, et al. 85 2015 Increased Right Ventricular Fatty Acid 26356218 Accumulation in Chronic Thromboembolic Pulmonary Hypertension. Li, et al. 86 2015 The Prognostic Value of 18F-FDG Uptake 26359560 2015437729 Ratio Between the Right and Left Ventricles in Idiopathic Pulmonary Arterial Hypertension. Drozd, et al. 87 2016 Effects of an endothelin receptor 27688036 20160703317 antagonist, Macitentan, on right ventricular substrate utilization and function in a Sugen 5416/hypoxia rat model of severe pulmonary arterial Brittain, et 2016 hypertension. Fatty Acid Metabolic Defects and Right 27006481 20160241851 al. 88 Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension. Talati, et al. 89 2016 Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor 27077479 Type 2 Mutant Right Ventricle. Joshi, et al. 90 2016 MicroRNA-140 is elevated and mitofusin-1 27422986 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension. Peters, et al. 91 2016 Regulation of myoglobin in hypertrophied rat cardiomyocytes in experimental 27572699 pulmonary hypertension. Sun, et al. 92 2016 Reversal of right ventricular remodeling by 26763846 20160371500 dichloroacetate is related to inhibition of mitochondria-dependent apoptosis. Van der 2016 Bone Morphogenetic Protein Receptor 26984938 Bruggen, et Type 2 Mutation in Pulmonary Arterial al. 93 Hypertension: A View on the Right Ventricle.